[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394-424.
[2] McGlynn KA, Petrick JL, London WT Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clin Liver Dis 2015; 19: 223-238.
[3] Hiraki A, Matsuo K, Suzuki T, et al. Teeth loss and risk of cancer at 14 common sites in Japanese. Cancer Epidemiol Biomarkers Prev 2008; 17: 1222-1227.
[4] Sakai H, Yamada SI, Gibo T, et al. A retrospective analysis of the prevalence of dental diseases in patients with digestive system cancers. Medicine (Baltimore) 2019; 98: e14771.
[5] Thistle JE, Yang B, Petrick JL, et al. Association of tooth loss with liver cancer incidence and chronic liver disease mortality in a rural Chinese population. PLoS One 2018; 13: e0203926.
[6] Yang B, Petrick JL, Abnet CC, et al. Tooth loss and liver cancer incidence in a Finnish cohort. Cancer Causes Control 2017; 28: 899-904.
[7] Meyle J, Chapple I Molecular aspects of the pathogenesis of periodontitis. Periodontol 2000 2015; 69: 7-17.
[8] Papapanou PN, Susin C Periodontitis epidemiology: is periodontitis under-recognized, over-diagnosed, or both? Periodontol 2000 2017; 75: 45-51.
[9] Pihlstrom BL, Michalowicz BS, Johnson NW Periodontal diseases. Lancet 2005; 366: 1809-1820.
[10] Beukers NG, van der Heijden GJ, van Wijk AJ, et al. Periodontitis is an independent risk indicator for atherosclerotic cardiovascular diseases among 60 174 participants in a large dental school in the Netherlands. J Epidemiol Community Health 2017; 71: 37-42.
[11] de Oliveira Ferreira R, de Brito Silva R, Magno MB, et al. Does periodontitis represent a risk factor for rheumatoid arthritis? A systematic review and meta-analysis. 2019; 11: 1759720x19858514.
[12] Moghadam SA, Shirzaiy M, Risbaf S The Associations between Periodontitis and Respiratory Disease. J Nepal Health Res Counc 2017; 15: 1-6.
[13] Alakhali MS, Al-Maweri SA The potential association between periodontitis and non-alcoholic fatty liver disease: a systematic review. 2018; 22: 2965-2974.
[14] Helenius-Hietala J, Suominen AL Periodontitis is associated with incident chronic liver disease-A population-based cohort study. 2019; 39: 583-591.
[15] Chen H, Nie S, Zhu Y, et al. Teeth loss, teeth brushing and esophageal carcinoma: a systematic review and meta-analysis. Sci Rep 2015; 5: 15203.
[16] Corbella S, Veronesi P, Galimberti V, et al. Is periodontitis a risk indicator for cancer? A meta-analysis. PLoS One 2018; 13: e0195683.
[17] Ma P, Dai S, Jin C, et al. Tooth loss and risk of colorectal cancer: a dose-response meta-analysis of prospective cohort studies. Onco Targets Ther 2018; 11: 1617-1623.
[18] Maisonneuve P, Amar S, Lowenfels AB Periodontal disease, edentulism, and pancreatic cancer: a meta-analysis. Ann Oncol 2017; 28: 985-995.
[19] Yin XH, Wang YD, Luo H, et al. Association between Tooth Loss and Gastric Cancer: A Meta-Analysis of Observational Studies. PLoS One 2016; 11: e0149653.
[20] Zeng XT, Xia LY, Zhang YG, et al. Periodontal Disease and Incident Lung Cancer Risk: A Meta-Analysis of Cohort Studies. J Periodontol 2016; 87: 1158-1164.
[21] Chung SD, Tsai MC, Huang CC, et al. A population-based study on the associations between chronic periodontitis and the risk of cancer. International Journal of Clinical Oncology 2016; 21: 219-223.
[22] Ray K Fusobacterium nucleatum found in colon cancer tissue-could an infection cause colorectal cancer. Nature Reviews Gastroenterology & Hepatology 2011; 8: 662.
[23] Ahn J, Segers S, Hayes RB Periodontal disease, Porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality. Carcinogenesis 2012; 33: 1055-1058.
[24] Gao S, Li S, Ma Z, et al. Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer. Infect Agent Cancer 2016; 11: 3.
[25] Nwizu NN, Marshall JR, Moysich K, et al. Periodontal Disease and Incident Cancer Risk among Postmenopausal Women: Results from the Women's Health Initiative Observational Cohort. Cancer Epidemiol Biomarkers Prev 2017; 26: 1255-1265.
[26] Tamaki N, Takaki A, Tomofuji T, et al. Stage of hepatocellular carcinoma is associated with periodontitis. J Clin Periodontol 2011; 38: 1015-1020.
[27] Ansai T, Takata Y, Yoshida A, et al. Association between tooth loss and orodigestive cancer mortality in an 80-year-old community-dwelling Japanese population: a 12-year prospective study. BMC Public Health 2013; 13: 814.
[28] Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic reviews 2015; 4: 1.
[29] Stang A Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European journal of epidemiology 2010; 25: 603-605.
[30] Jordão HW, McKenna G, McMenamin ÚC, et al. The association between self-reported poor oral health and gastrointestinal cancer risk in the UK Biobank: A large prospective cohort study. United European Gastroenterology Journal 2019: 2050640619858043.
[31] Javed F, Warnakulasuriya S Is there a relationship between periodontal disease and oral cancer? A systematic review of currently available evidence. Crit Rev Oncol Hematol 2016; 97: 197-205.
[32] Ren HG, Luu HN, Cai H, et al. Oral health and risk of colorectal cancer: results from three cohort studies and a meta-analysis. Ann Oncol 2016; 27: 1329-1336.
[33] Coussens LM, Werb Z Inflammation and cancer. Nature 2002; 420: 860-867.
[34] Mantovani A, Savino B, Locati M, et al. The chemokine system in cancer biology and therapy. Cytokine Growth Factor Rev 2010; 21: 27-39.
[35] Zhang Y, Niu Q, Fan W, et al. Oral microbiota and gastrointestinal cancer. Onco Targets Ther 2019; 12: 4721-4728.
[36] Stashenko P, Yost S, Choi Y, et al. The Oral Mouse Microbiome Promotes Tumorigenesis in Oral Squamous Cell Carcinoma. mSystems 2019; 4.
[37] Ahn J, Chen CY, Hayes RB Oral microbiome and oral and gastrointestinal cancer risk. Cancer Causes Control 2012; 23: 399-404.
[38] Kostic AD, Chun E, Robertson L, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell host & microbe 2013; 14: 207-215.
[39] Castellarin M, Warren RL, Freeman JD, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 2012; 22: 299-306.
[40] Weintraub JA, Lopez Mitnik G, Dye BA Oral Diseases Associated with Nonalcoholic Fatty Liver Disease in the United States. J Dent Res 2019: 22034519866442.
[41] Alazawi W, Bernabe E Periodontitis is associated with significant hepatic fibrosis in patients with non-alcoholic fatty liver disease. 2017; 12: e0185902.
[42] Costa FO, Lages EJP, Lages EMB, et al. Periodontitis in individuals with liver cirrhosis: a case-control study. J Clin Periodontol 2019.
[43] Nakahara T, Hyogo H, Ono A, et al. Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease. 2018; 53: 269-280.
[44] Yoneda M, Naka S, Nakano K, et al. Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease. BMC Gastroenterol 2012; 12: 16.
[45] Omura Y, Kitamoto M, Hyogo H, et al. Morbidly obese patient with non-alcoholic steatohepatitis-related cirrhosis who died from sepsis caused by dental infection of Porphyromonas gingivalis: A case report. Hepatol Res 2016; 46: E210-215.
[46] Nakajima M, Arimatsu K, Kato T, et al. Oral administration of P. gingivalis induces dysbiosis of gut microbiota and impaired barrier function leading to dissemination of enterobacteria to the liver. Plos one 2015; 10: e0134234.
[47] Schwabe RF, Jobin C The microbiome and cancer. Nat Rev Cancer 2013; 13: 800-812.